Related Experiment Video

Updated: Aug 9, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility

Remco van Horssen1, Timo L M Ten Hagen, Alexander M M Eggermont

  • 1Department of Surgical Oncology, Erasmus MC--Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.

The Oncologist
|April 15, 2006
PubMed

Insights

Tumor necrosis factor alpha (TNF-alpha) is a key cytokine in cancer treatment, enhancing cytostatic drug efficacy. It targets tumor vasculature, causing necrosis and drug accumulation for improved antitumor activity.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Tumor necrosis factor alpha (TNF-alpha) is a cytokine with diverse roles in immunity, inflammation, apoptosis, and cell survival.
  • While known for antitumor properties, TNF-alpha is implicated in various diseases.
  • Current clinical applications include regional cancer treatment for unresectable tumors, often in combination with cytostatic drugs.

Purpose of the Study:

  • To review the multifaceted roles of TNF-alpha in cancer treatment.
  • To elucidate the molecular mechanisms underlying TNF-alpha's antitumor activities.
  • To provide an overview from molecular insights to clinical applications and response.

Main Methods:

  • Review of existing literature on TNF-alpha signaling and antitumor mechanisms.
  • Analysis of TNF-alpha's interaction with TNF receptors (TNFR-1, TNFR-2).
  • Examination of TNF-alpha's effects on tumor-associated vasculature (TAV) and drug delivery.

Main Results:

  • TNF-alpha synergizes with cytostatic drugs in cancer therapy.
  • TNF-alpha induces hemorrhagic necrosis and targets tumor vasculature, increasing drug accumulation.
  • TNFR-1 signaling pathways are involved, though regulation remains incompletely understood.

Conclusions:

  • TNF-alpha exhibits significant antitumor potential through vascular targeting and synergistic effects with chemotherapy.
  • Further research into TNF-alpha signaling regulation is needed.
  • TNF-alpha represents a valuable therapeutic agent in oncology, particularly in regional treatment settings.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...